Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
FDA PRE-APPROVAL INSPECTIONS: "PLANT NOT CAPABLE" IS MOST FREQUENT REASON
Apr 12 1993
•
By
The Pink Sheet
More from Archive
More from Pink Sheet